Study: Birth Pill Protects Against Ovarian Cancer

The contraceptive Pill gives women substantial and long-lasting protection against ovarian cancer, according to a new report led by Oxford scientists published in The Lancet.

The researchers found that the protection against ovarian cancer lasted for more than 30 years after women had stopped taking the Pill. They also found that the longer the Pill was used the greater the protection and that taking the Pill for 15 years halved the risk of ovarian cancer.

Researchers estimated that, in high income countries, using oral contraceptives for ten years reduces the risk of developing ovarian cancer before the age of 75 from 12 down to 8 per 1000 women, and reduces the risk of death from ovarian cancer before age 75 from 7 down to 5 per 1000 women.

The new report brings together worldwide evidence from 45 epidemiological studies of ovarian cancer in 21 countries. These include 23,257 women with ovarian cancer of whom 7,308 (31 per cent) had used oral contraceptives and 87,303 women without ovarian cancer of whom 32,717 (37 per cent) had used oral contraceptives.

The study, led by Oxford University researchers, was conducted by the Collaborative Group on Epidemiological Studies of Ovarian Cancer, a collaboration involving 120 researchers from around the world. The work was supported by Cancer Research UK and the Medical Research Council.

Lead author Professor Valerie Beral, director of the Cancer Research UK Epidemiology Unit at Oxford University, said: ‘Worldwide, the Pill has already prevented 200,000 women from developing cancer of the ovary and has prevented 100,000 deaths from the disease. More than 100 million women are now taking the Pill, so the number of ovarian cancers prevented will rise over the next few decades to about 30,000 per year.’

The Pill also causes long-lasting protection against endometrial cancer (cancer or the lining of the womb) but causes a short-lived increase in breast cancer and in cervical cancer (cancer of the neck of the womb). Co-author Sir Richard Peto, Professor of Epidemiology at Oxford University, said: ‘Young women don’t have to worry about cancer from taking the Pill because the eventual reduction in ovarian cancer is bigger than any increase in other types of cancer caused by the Pill.’

Young women take the Pill mostly for contraceptive purposes. There are known to be some definite health risks among current or recent users. But these are outweighed by the long-term protective effects against ovarian cancer – one of the most dangerous types of cancer.

Source: Oxford University

Related stories:

Chemical compound prevents cancer in lab
While researching new ways to stop the progression of cancer, researchers at the University of Oklahoma Health Sciences Center, have discovered a compound that has shown to prevent cancer in the laboratory. The research appears in the journal Gene Regulation and Systems Biology.
Taking the contraceptive pill may reduce the risk of developing cancer
Taking the contraceptive pill does not increase a woman’s chances of developing cancer and may even reduce the risk for most women, according to a study published in BMJ today.
The abortion pill compound prevents breast tumor growth
The chemical compound for the abortion pill has been found to prevent the growth of mammary tumors caused by the mutant gene responsible for a majority of breast and ovarian cancers, according to UC Irvine scientists.
New approach to genetic testing could halve deaths from inherited bowel cancer
Changing the approach to genetic screening for cancers in Australia could effectively halve deaths caused by an inherited form of bowel cancer, says a University of Melbourne expert.
Just a numbers game? Making sense of health statistics
Presidential candidates use them to persuade voters, drug companies use them to sell their products, and the media spin them in all kinds of ways, but nobody - candidates, reporters, let alone health consumers - understands them. Health statistics fill today's information environment, but even most doctors, who must make daily decisions and recommendations based on numerical data - for instance, to calculate the risks of a certain drug or surgical intervention, or to inform a patient of the possible benefits versus harms of cancer screening - lack the basic statistical literacy they require to make such decisions effectively.
Net widens as more proteins implicated in cancer spread
(PhysOrg.com) -- Authorities are on the lookout for 64 proteins believed to have been talking to well-known cancer kingpin urokinase plasminogen activator receptor (a.k.a uPAR).
Disease diagnosis in just 15 minutes
Testing for diseases such as cancer and multiple sclerosis could soon be as simple as using a pregnancy testing kit.
Bio-imaging mass spectrometry techniques reveal molecular details about complex systems
Understanding biology at the systems level is difficult, especially when studying complex specimens like tissue slices or communities of organisms in a biofilm. Scientists must be able to identify, quantify and locate the molecules present in the samples.

News discussion:

Medicine & Health news